Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

[Gastric cancer screening using ABC classification].

Inoue K.

Nihon Rinsho. 2012 Oct;70(10):1790-4. Japanese.

PMID:
23198563
2.

[Gastric cancer risk classification (ABC classification)].

Inoue K.

Nihon Rinsho. 2013 Aug;71(8):1472-8. Review. Japanese.

PMID:
23967682
3.

Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.

Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, Sakagami S, Ishida S.

Digestion. 2016;93(1):13-8. doi: 10.1159/000441742. Epub 2016 Jan 14. Review.

4.

Analysis of ABC (D) stratification for screening patients with gastric cancer.

Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, Mori M.

World J Gastroenterol. 2011 Nov 21;17(43):4793-8. doi: 10.3748/wjg.v17.i43.4793.

5.

'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.

Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bò N, Iori V, Pilotto A, Leandro G, Franzè A, Rugge M.

Scand J Gastroenterol. 2003 Dec;38(12):1223-7.

PMID:
14750641
6.

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M.

Gut. 2005 Jun;54(6):764-8.

9.

Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M.

Gut. 2001 Sep;49(3):335-40.

10.

Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.

Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, Mabe K, Shimizu Y.

Digestion. 2012;86(1):59-65. doi: 10.1159/000339176. Epub 2012 Jun 20.

PMID:
22722747
11.

Clinical significance of IgG antibody titer against Helicobacter pylori.

Tatemichi M, Sasazuki S, Inoue M, Tsugane S; JPHC Study Group.

Helicobacter. 2009 Jun;14(3):231-6. doi: 10.1111/j.1523-5378.2009.00681.x.

PMID:
19702853
12.

Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.

Tatemichi M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center Study Group.

Acta Oncol. 2008;47(3):360-5. doi: 10.1080/02841860701843035.

PMID:
18347999
13.

Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.

Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T, Takaku R, Hamashima C.

PLoS One. 2014 Oct 14;9(10):e109783. doi: 10.1371/journal.pone.0109783. eCollection 2014. Review.

14.

Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).

Nordenstedt H, Nilsson M, Johnsen R, Lagergren J, Hveem K.

Helicobacter. 2007 Feb;12(1):16-22.

PMID:
17241296
15.

[Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].

Sun LP, Gong YH, Wang L, Gong W, Yuan Y.

Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2826-30. Chinese.

PMID:
17200016
16.

Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.

Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):627-30.

17.

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Parsonnet J, Friedman GD, Orentreich N, Vogelman H.

Gut. 1997 Mar;40(3):297-301.

18.

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Härkönen M, Hakama MK.

Am J Epidemiol. 1996 Jul 15;144(2):142-9.

PMID:
8678045
19.

[Tumor markers in gastric cancer].

Ohkura H.

Gan To Kagaku Ryoho. 2002 Apr;29(4):637-43. Japanese.

PMID:
11977555
20.

[Chronic gastritis: last decade's achievements and problems].

Pimanov SI, Makarenko EV.

Klin Med (Mosk). 2005;83(1):54-8. Review. Russian.

PMID:
15759493

Supplemental Content

Support Center